Compound Evidence File
#EC-2026-0026
1-Testosterone Cypionate (DHB) Raw
Filed under Raw Materials. The bureau holds 117 laboratory returns for this compound from 32 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
32 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 8 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 5 | 10.0 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| BachemCASE #VI-2026-0314 | A | 4 | 10.0 | 9.9 | 10.0 | 8 Nov 2025 | 8 Apr 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 10.0 | 9.9 | 10.0 | 1 Jan 2026 | 7 Jul 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 3 | 10.0 | 10.0 | 10.0 | 9 May 2026 | 9 Jul 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 3 | 10.0 | 9.9 | 10.0 | 28 Nov 2025 | 17 Jun 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 3 | 10.0 | 9.9 | 10.0 | 19 Jan 2026 | 11 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 3 | 10.0 | 9.9 | 10.0 | 11 May 2026 | 28 Jun 2026 |
| Peptide TechnologiesCASE #VI-2026-0694 | X | 1 | 10.0 | 10.0 | 10.0 | 27 Feb 2025 | 27 Feb 2025 |
| WuXi TIDESCASE #VI-2026-0335 | A | 5 | 9.9 | 9.9 | 10.0 | 3 May 2026 | 1 Jul 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 4 | 9.9 | 9.9 | 10.0 | 11 Dec 2025 | 17 Jun 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 2 | 9.9 | 9.9 | 10.0 | 3 Apr 2026 | 9 May 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 2 | 9.9 | 9.9 | 10.0 | 2 Feb 2026 | 20 May 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 2 | 9.9 | 9.9 | 9.9 | 10 Nov 2025 | 8 Mar 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 2 | 9.9 | 9.9 | 10.0 | 13 May 2026 | 7 Jul 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 2 | 9.9 | 9.9 | 10.0 | 25 Dec 2025 | 1 Jun 2026 |
| NUPEPS PeptidesCASE #VI-2026-0896 | X | 1 | 8.9 | 8.9 | 8.9 | 27 Feb 2025 | 27 Feb 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 8 | 8.6 | 8.0 | 9.3 | 24 May 2026 | 24 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 5 | 8.4 | 6.7 | 9.7 | 24 May 2026 | 24 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 6 | 8.2 | 7.4 | 9.5 | 24 May 2026 | 24 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 4 | 8.1 | 6.7 | 9.5 | 24 May 2026 | 24 May 2026 |
| HkRoidsCASE #VI-2026-0784 | X | 1 | 8.0 | 8.0 | 8.0 | 13 Feb 2025 | 13 Feb 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 5 | 7.8 | 6.0 | 9.8 | 21 May 2026 | 21 May 2026 |
| Reta-PeptideCASE #VI-2026-0756 | X | 10 | 7.3 | 5.7 | 10.0 | 6 May 2025 | 24 May 2026 |
| Glamgurcraft Innovations Foreign TradeCASE #VI-2026-0348 | X | 1 | 7.1 | 7.1 | 7.1 | 14 Jan 2025 | 14 Jan 2025 |
| ZLZ PeptideCASE #VI-2026-0524 | X | 15 | 7.0 | 4.4 | 10.0 | 17 Dec 2024 | 21 May 2026 |
| TydesCASE #VI-2026-0493 | X | 2 | 6.7 | 6.6 | 6.7 | 27 Feb 2025 | 20 May 2026 |
| Xingtai Jiachuang TechnologyCASE #VI-2026-0712 | X | 2 | 6.2 | 5.3 | 7.2 | 21 May 2025 | 21 May 2026 |
| Evolve BioPepCASE #VI-2026-0755 | X | 1 | 5.3 | 5.3 | 5.3 | 17 Dec 2024 | 17 Dec 2024 |
| Shaanxi Dideu MedichemCASE #VI-2026-0499 | X | 1 | 4.5 | 4.5 | 4.5 | 28 Mar 2025 | 28 Mar 2025 |
| PeptiLab ResearchCASE #VI-2026-0267 | X | 1 | 3.0 | 3.0 | 3.0 | 14 Jan 2025 | 14 Jan 2025 |
| Advanced Technology and IndustrialCASE #VI-2026-0133 | X | 1 | 1.7 | 1.7 | 1.7 | 2 Jul 2025 | 2 Jul 2025 |
Open any subject to view the batch-level evidence for 1-Testosterone Cypionate (DHB) Raw alone.